Latest Capital Markets News

A1 Investments & Resources Ltd reported a modest cash outflow for Q1 2024 while actively pursuing renewable energy acquisitions in Japan and Australia, contingent on regulatory approvals and shareholder consent.

OncoSil Medical has secured new distribution agreements across key international markets and achieved critical regulatory milestones, while raising $8 million to fuel its growth in pancreatic cancer treatment.

NGX Limited reports significant progress in its uranium exploration in Namibia and graphite development in Malawi, alongside strategic leadership changes and a strong financial position.

Wisr has reported a robust Q2FY25 with loan originations surging 77% year-on-year to $93.5 million, alongside improving credit metrics and a well-capitalised balance sheet.

VRX Silica Limited has achieved a major milestone with the EPA recommending approval for its Arrowsmith North Silica Sand Project, alongside securing $5 million in capital and expanding offtake agreements.

Dreadnought Resources has strategically acquired tenement E09/2383, consolidating its Mangaroon Gold Project and unlocking access to high-grade gold mineralisation at the Jailor target. This move sets the stage for intensified exploration activities starting February 2025.

Xstate Resources reports steady oil and gas production while navigating ASX suspension and preparing for capital raising tied to a new project announcement.

ReNu Energy has raised $500,000 through loan notes that may convert into shares and options pending shareholder approval, aiming to bolster working capital.

Euroz Hartleys Group reports a striking 501% jump in net profit for H1 FY2025, driven by strong capital raising and diversified revenue streams, prompting a dividend increase to 2 cents per share.

Associate Global Partners Limited (AGP) reported its strongest quarterly net inflows since 2017, driving funds under management to $1.72 billion amid successful capital raising and robust investment performance.

PVW Resources has appointed Lucas Stanfield as CEO, bringing rare earths project expertise to accelerate development of its Brazilian assets. Stanfield’s leadership marks a strategic pivot towards advancing critical mineral projects in a globally significant mining jurisdiction.

Artrya Limited reports solid progress on its FDA 510(k) application and secures a A$5 million capital raise, positioning itself for imminent commercial rollout in the US healthcare sector.